{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:51:46Z","timestamp":1790887906952,"version":"4.1.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Urinary tract infections (UTIs) are common and burdensome in women. Here, we discuss challenges with our current models of care and how evolving insights into the female urogenital microbiome have advanced the understanding of how we diagnose, treat, and prevent recurrent UTIs in nonpregnant adult women. Traditional care models attribute recurrent UTIs mainly to gastrointestinal sources, resulting in significant emphasis on eradicating pathogens with potential overreliance on antibiotics. Evidence now shows that the bladder harbors a complex microbiome, with interactions between the urinary and vaginal environments and immune mechanisms at the bladder mucosal surface influencing infection susceptibility. Thus, in updated models of care, more emphasis is placed on enhancing the protective microbiome. This may be especially important in postmenopausal women, who experience microbiome shifts that increase vulnerability to recurrent infections, underscoring the role of estrogen therapy and microbiome-supportive interventions. Updated treatment approaches emphasize antimicrobial stewardship, advocating for confirmation of the diagnosis and delayed antibiotic initiation when safe, and judicious use of antibiotics for symptom relief. Prevention strategies highlight the importance of vaginal estrogen, methenamine salts, and other supplements rather than exclusive reliance on prophylactic antibiotics. Ongoing research into emerging therapies such as UTI vaccines and bacteriophage drugs may further decrease our reliance on antibiotics in the future. This clinical update underscores the need for individualized care plans that balance effective infection management while minimizing antibiotic-related harms, emphasizing a holistic, microbiome-centered approach to recurrent UTI prevention and treatment.<\/jats:p>","DOI":"10.1097\/aog.0000000000006060","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T21:00:28Z","timestamp":1757019628000},"page":"631-644","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Updates in Clinical Management of Recurrent Urinary Tract Infections"],"prefix":"10.1097","volume":"146","author":[{"given":"Nazema Y.","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"R1-20260824","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/pathogens12040623","article-title":"Urinary tract infections: the current scenario and future prospects","volume":"12","author":"Mancuso","year":"2023","journal-title":"Pathogens"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat Rev Urol"},{"key":"R4-20260824","first-page":"1","article-title":"Ambulatory medical care utilization estimates for 2007","volume":"13","author":"Schappert","year":"2011","journal-title":"Vital Health Stat"},{"key":"R5-20260824","first-page":"41","article-title":"Management of recurrent urinary tract infections in healthy adult women","volume":"15","author":"Hickling","year":"2013","journal-title":"Rev Urol"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/ciz021","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","author":"Nicolle","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/phar.1437","article-title":"Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults: a systematic review","volume":"34","author":"Dull","year":"2014","journal-title":"Pharmacotherapy"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000003874","article-title":"Proposing the \u201ccontinuum of UTI\u201d for a nuanced approach to diagnosis and management of urinary tract infections","volume":"211","author":"Advani","year":"2024","journal-title":"J Urol"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice: uncomplicated urinary tract infection","volume":"366","author":"Hooton","year":"2012","journal-title":"N Engl J Med"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/JU.0000000000000296","article-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline","volume":"202","author":"Anger","year":"2019","journal-title":"J Urol"},{"key":"R11-20260824","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/AOG.0000000000005746","article-title":"Trends in urinary tract infection management in women","volume":"145","author":"Yadav","year":"2025","journal-title":"Obstet Gynecol"},{"key":"R12-20260824","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cid\/ciz764","article-title":"Outpatient urinary tract infections in an era of virtual healthcare: trends from 2008 to 2017","volume":"71","author":"Bruxvoort","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R14-20260824","doi-asserted-by":"crossref","first-page":"321082","DOI":"10.1155\/2010\/321082","article-title":"Genetic risk for recurrent urinary tract infections in humans: a systematic review","volume":"2010","author":"Zaffanello","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/GME.0000000000001209","article-title":"The mysteries of menopause and urogynecologic health: clinical and scientific gaps","volume":"26","author":"Alperin","year":"2019","journal-title":"Menopause"},{"key":"R16-20260824","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/JCM.05852-11","article-title":"Evidence of uncultivated bacteria in the adult female bladder","volume":"50","author":"Wolfe","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R17-20260824","doi-asserted-by":"crossref","first-page":"154.e1","DOI":"10.1016\/j.ajog.2019.08.011","article-title":"Defining the relationship between vaginal and urinary microbiomes","volume":"222","author":"Komesu","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20260824","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-018-03968-5","article-title":"Culturing of female bladder bacteria reveals an interconnected urogenital microbiota","volume":"9","author":"Thomas-White","year":"2018","journal-title":"Nat Commun"},{"key":"R19-20260824","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/13697137.2018.1551871","article-title":"The etiology and management of recurrent urinary tract infections in postmenopausal women","volume":"22","author":"Jung","year":"2019","journal-title":"Climacteric"},{"key":"R20-20260824","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/GME.0b013e3182a4690b","article-title":"Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy","volume":"21","author":"Brotman","year":"2014","journal-title":"Menopause"},{"key":"R21-20260824","doi-asserted-by":"crossref","first-page":"100753","DOI":"10.1016\/j.xcrm.2022.100753","article-title":"Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome","volume":"3","author":"Neugent","year":"2022","journal-title":"Cell Rep Med"},{"key":"R22-20260824","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1371\/journal.pmed.0040329","article-title":"Detection of intracellular bacterial communities in human urinary tract infection","volume":"4","author":"Rosen","year":"2007","journal-title":"PLoS Med"},{"key":"R23-20260824","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.jmb.2019.04.008","article-title":"Direct detection of tissue-resident bacteria and chronic inflammation in the bladder wall of postmenopausal women with recurrent urinary tract infection","volume":"431","author":"De Nisco","year":"2019","journal-title":"J Mol Biol"},{"key":"R24-20260824","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/nau.24471","article-title":"Sporadic compared to recurrent urinary tract infections: considerations for urogynecologic patients","volume":"39","author":"Bradley","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"R25-20260824","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1097\/SPV.0000000000000778","article-title":"Impact of menopausal status on uropathogen prevalence and antimicrobial resistance profiles","volume":"27","author":"Venuti","year":"2021","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R26-20260824","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41590-020-0688-3","article-title":"A highly polarized T(H)2 bladder response to infection promotes epithelial repair at the expense of preventing new infections","volume":"21","author":"Wu","year":"2020","journal-title":"Nat Immunol"},{"key":"R27-20260824","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nri3887","article-title":"The nature of immune responses to urinary tract infections","volume":"15","author":"Abraham","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"R28-20260824","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/JU.0000000000001940","article-title":"The urinary microbiome in postmenopausal women with recurrent urinary tract infections","volume":"206","author":"Vaughan","year":"2021","journal-title":"J Urol"},{"key":"R29-20260824","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.archger.2011.07.012","article-title":"Clinical presentation of urinary tract infection (UTI) differs with aging in women","volume":"55","author":"Arinzon","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"key":"R30-20260824","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/AOG.0000000000002239","article-title":"Urinary symptoms and their associations with urinary tract infections in urogynecologic patients","volume":"130","author":"Dune","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R31-20260824","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1532-5415.2009.02227.x","article-title":"Clinical features to identify urinary tract infection in nursing home residents: a cohort study","volume":"57","author":"Juthani-Mehta","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"R32-20260824","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/JU.0000000000002860","article-title":"Updates to recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline","volume":"208","author":"Anger","year":"2022","journal-title":"J Urol"},{"key":"R33-20260824","doi-asserted-by":"crossref","first-page":"c2096","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"Costelloe","year":"2010","journal-title":"BMJ"},{"key":"R34-20260824","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1017\/ice.2023.106","article-title":"Implementing diagnostic stewardship to improve diagnosis of urinary tract infections across three medical centers: a qualitative assessment","volume":"44","author":"Claeys","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R35-20260824","article-title":"EAU guidelines on urological infections. Edn. presented at the EAU Annual Congress Madrid, Spain 2025","author":"Bonkat","journal-title":"ISBN"},{"key":"R36-20260824","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder","volume":"52","author":"Hilt","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R37-20260824","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/JU.0000000000001949","article-title":"A randomized clinical trial of standard versus expanded cultures to diagnose urinary tract infections in women","volume":"206","author":"Barnes","year":"2021","journal-title":"J Urol"},{"key":"R38-20260824","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/nau.24707","article-title":"Recurrent urinary tract infection: association of clinical profiles with urobiome composition in women","volume":"40","author":"Burnett","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"R39-20260824","first-page":"213","article-title":"A head-to-head comparative phase II study of standard urine culture and sensitivity versus DNA next-generation sequencing testing for urinary tract infections","volume":"19","author":"McDonald","year":"2017","journal-title":"Rev Urol"},{"key":"R40-20260824","doi-asserted-by":"crossref","first-page":"116646","DOI":"10.1016\/j.diagmicrobio.2024.116646","article-title":"Clinical utility of PCR compared to conventional culture and sensitivity testing for management of complicated urinary tract infections in adults: part II: evaluation of diagnostic concordance, discordant results, and antimicrobial selection efficacy","volume":"111","author":"Spangler","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R41-20260824","doi-asserted-by":"crossref","first-page":"116601","DOI":"10.1016\/j.diagmicrobio.2024.116601","article-title":"Clinical utility of PCR compared to conventional culture and sensitivity testing for the management of complicated urinary tract infections in adults: part I: assessment of clinical outcomes, investigator satisfaction scores, and turnaround times","volume":"111","author":"Spangler","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R42-20260824","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.3390\/diagnostics13193060","article-title":"Improving patient outcomes while reducing empirical treatment with multiplex-polymerase-chain-reaction\/pooled-antibiotic-susceptibility-testing assay for complicated and recurrent urinary tract infections","volume":"13","author":"Haley","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R43-20260824","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11934-018-0839-3","article-title":"Recurrent urinary tract infections in females and the overlap with overactive bladder","volume":"19","author":"Nik-Ahd","year":"2018","journal-title":"Curr Urol Rep"},{"key":"R44-20260824","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2296-14-71","article-title":"Women with symptoms of uncomplicated urinary tract infection are often willing to delay antibiotic treatment: a prospective cohort study","volume":"14","author":"Knottnerus","year":"2013","journal-title":"BMC Fam Pract"},{"key":"R45-20260824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/02813430601183074","article-title":"Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project","volume":"25","author":"Ferry","year":"2007","journal-title":"Scand J Prim Health Care"},{"key":"R46-20260824","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"},{"key":"R47-20260824","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jinf.2008.12.009","article-title":"Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials","volume":"58","author":"Falagas","year":"2009","journal-title":"J Infect"},{"key":"R48-20260824","doi-asserted-by":"crossref","first-page":"c199","DOI":"10.1136\/bmj.c199","article-title":"Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial","volume":"340","author":"Little","year":"2010","journal-title":"BMJ"},{"key":"R49-20260824","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.3399\/bjgp20X712781","article-title":"Natural history of uncomplicated urinary tract infection without antibiotics: a systematic review","volume":"70","author":"Hoffmann","year":"2020","journal-title":"Br J Gen Pract"},{"key":"R50-20260824","doi-asserted-by":"crossref","first-page":"l525","DOI":"10.1136\/bmj.l525","article-title":"Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study","volume":"364","author":"Gharbi","year":"2019","journal-title":"BMJ"},{"key":"R51-20260824","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00192-022-05132-6","article-title":"Incidence of urosepsis or pyelonephritis after uncomplicated urinary tract infection in older women","volume":"33","author":"Bradley","year":"2022","journal-title":"Int Urogynecol J"},{"key":"R52-20260824","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/IM9.0000000000000020","article-title":"Efficacy of nonsteroidal anti-inflammatory drugs for treatment of uncomplicated lower urinary tract infections in women: a meta-analysis","volume":"2","author":"Zhang","year":"2020","journal-title":"Infect Microbes Dis"},{"key":"R53-20260824","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R55-20260824","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cid\/ciae621","article-title":"Safety and tolerability of pivmecillinam during more than four decades of clinical experience: a systematic review","volume":"80","author":"Kaye","year":"2025","journal-title":"Clin Infect Dis"},{"key":"R58-20260824","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/17460913.2025.2460387","article-title":"Plain language summary: efficacy and safety of gepotidacin, a new oral antibiotic, compared with nitrofurantoin, a commonly used oral antibiotic, for treating uncomplicated urinary tract infection","volume":"20","author":"Wagenlehner","year":"2025","journal-title":"Future Microbiol"},{"key":"R59-20260824","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(23)02196-7","article-title":"Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials","volume":"403","author":"Wagenlehner","year":"2024","journal-title":"Lancet"},{"key":"R60-20260824","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkac404","article-title":"Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA\/SHEA, ESCMID and ASID guidelines","volume":"78","author":"Bishop","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"R61-20260824","doi-asserted-by":"crossref","first-page":"e015233","DOI":"10.1136\/bmjopen-2016-015233","article-title":"Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials","volume":"7","author":"Ahmed","year":"2017","journal-title":"BMJ Open"},{"key":"R62-20260824","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPV.0000000000000550","article-title":"American urogynecologic society best-practice statement: recurrent urinary tract infection in adult women","volume":"24","author":"Brubaker","year":"2018","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R63-20260824","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/AOG.0b013e318185f7a5","article-title":"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women","volume":"112","author":"Perrotta","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R64-20260824","doi-asserted-by":"crossref","first-page":"727.e1","DOI":"10.1016\/j.ajog.2020.08.006","article-title":"Vaginal estrogen therapy is associated with increased lactobacillus in the urine of postmenopausal women with overactive bladder symptoms","volume":"223","author":"Thomas-White","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R65-20260824","first-page":"CD008772","article-title":"Probiotics for preventing urinary tract infections in adults and children","volume":"12","author":"Schwenger","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R66-20260824","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s42003-021-02394-6","article-title":"Vaginal microbiome Lactobacillus crispatus is heritable among European American women","volume":"4","author":"Wright","year":"2021","journal-title":"Commun Biol"},{"key":"R67-20260824","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1093\/infdis\/jiaa676","article-title":"Connecting the dots: translating the vaginal microbiome into a drug","volume":"223","author":"Lagenaur","year":"2021","journal-title":"J Infect Dis"},{"key":"R68-20260824","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/cid\/cir183","article-title":"Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection","volume":"52","author":"Stapleton","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R69-20260824","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/cid\/ciad766","article-title":"Effectiveness of prophylactic oral and\/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: a randomized, double-blind, placebo-controlled trial","volume":"78","author":"Gupta","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R70-20260824","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.juro.2007.01.114","article-title":"Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells","volume":"177","author":"Gupta","year":"2007","journal-title":"J Urol"},{"key":"R71-20260824","first-page":"CD001321","article-title":"Cranberries for preventing urinary tract infections","volume":"11","author":"Williams","year":"2023","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R72-20260824","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3390\/nu16132113","article-title":"Supplementation with highly standardized cranberry extract phytosome achieved the modulation of urinary tract infection episodes in diabetic postmenopausal women taking SGLT-2 inhibitors: a RCT study","volume":"16","author":"Rondanelli","year":"2024","journal-title":"Nutrients"},{"key":"R73-20260824","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00345-023-04741-0","article-title":"Randomized, placebo-controlled, double-blinded study of prophylactic cranberries use in women with recurrent uncomplicated cystitis","volume":"42","author":"Tsiakoulias","year":"2024","journal-title":"World J Urol"},{"key":"R74-20260824","doi-asserted-by":"crossref","first-page":"265.e1","DOI":"10.1016\/j.ajog.2020.05.048","article-title":"D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis","volume":"223","author":"Lenger","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R75-20260824","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamainternmed.2024.0264","article-title":"d-Mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial","volume":"184","author":"Hayward","year":"2024","journal-title":"JAMA Intern Med"},{"key":"R76-20260824","doi-asserted-by":"crossref","first-page":"e068229","DOI":"10.1136\/bmj-2021-0068229","article-title":"Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial","volume":"376","author":"Harding","year":"2022","journal-title":"BMJ"},{"key":"R77-20260824","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"key":"R78-20260824","doi-asserted-by":"crossref","first-page":"e0003723","DOI":"10.1128\/aac.00037-23","article-title":"Therapeutic potential of intravenous phage as standalone therapy for recurrent drug-resistant urinary tract infections","volume":"67","author":"Le","year":"2023","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:12:34Z","timestamp":1787577154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006060","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"2025-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}